1
|
Sah R, Hada V, Mohanty A, Padhi B, Chandran D, Hussein NR, Emran TB, Chaicumpa W, Dhama K. Re-emergence of Sudan ebolavirus after a decade: new challenge to Ebola control. Int J Surg 2023; 109:131-133. [PMID: 36799826 PMCID: PMC10389555 DOI: 10.1097/js9.0000000000000089] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/07/2022] [Accepted: 11/20/2022] [Indexed: 02/18/2023]
Affiliation(s)
- Ranjit Sah
- Harvard Medical School, Boston, Massachusetts, USA
- Tribhuvan University Teaching Hospital, Institute of Medicine, Kathmandu, Nepal
| | - Vivek Hada
- Department of Clinical Microbiology, All India Institute of Medical Sciences, Gorakhpur, Uttar Pradesh
| | - Aroop Mohanty
- Department of Clinical Microbiology, All India Institute of Medical Sciences, Gorakhpur, Uttar Pradesh
| | - Bijaya Padhi
- Department of Community Medicine & School of Public Health, Postgraduate Institute of Medical Education and Research (PGIMER), Chandigarh, Chandigarh
| | - Deepak Chandran
- Department of Veterinary Sciences and Animal Husbandry, Amrita School of Agricultural Sciences, Amrita Vishwa Vidyapeetham University, Coimbatore, Tamil Nadu, India
| | - Nawfal R Hussein
- Department of Biomedical Sciences, College of Medicine, University of Zakho, Zakho, Kurdistan Region of Iraq, Iraq
| | - Talha B Emran
- Department of Pharmacy, BGC Trust University Bangladesh, Chittagong
- Department of Pharmacy, Faculty of Allied Health Sciences, Daffodil International University, Dhaka, Bangladesh
| | - Wanpen Chaicumpa
- Department of Parasitology, Center of Research Excellence in Therapeutic Proteins and Antibody Engineering, Faculty of Medicine Siriraj Hospital, Mahidol University, Bangkok, Thailand
| | - Kuldeep Dhama
- Division of Pathology, ICAR-Indian Veterinary Research Institute, Bareilly,Uttar Pradesh, India
| |
Collapse
|
2
|
Al-Tammemi AB, Sallam M, Rebhi A, Soliman L, Al Sarayrih L, Tarhini Z, Abutaima R, Aljaberi MA, Barakat M. The outbreak of Ebola virus disease in 2022: A spotlight on a re-emerging global health menace. NARRA J 2022; 2:e97. [PMID: 38449901 PMCID: PMC10914067 DOI: 10.52225/narra.v2i3.97] [Citation(s) in RCA: 5] [Impact Index Per Article: 1.7] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Subscribe] [Scholar Register] [Received: 11/15/2022] [Accepted: 12/10/2022] [Indexed: 03/08/2024]
Abstract
Ebola virus disease (EVD) is a rare but highly contagious and lethal disease that occurs predominantly in African countries, with a case-fatality rate of 30-90%. The causative viral pathogens of EVD are within the genus Ebolavirus in the family Filoviridae. The primary route of human-to-human transmission is through direct contact with blood, bodily fluids and secretions from infected individuals. Direct contact with virally contaminated objects and sexual transmission have also been reported. Management of EVD is aggressive supportive care with possibly new therapeutic options. On 20 September 2022, an EVD outbreak was declared in Uganda, caused by Sudan ebolavirus. As of 7 November 2022, a total of 136 confirmed cases, 53 confirmed deaths have been reported, including 18 cases with seven deaths among healthcare workers. In the Democratic Republic of Congo (DRC), an EVD outbreak was also declared on 22 August 2022 (which ended on 27 September 2022); with only one case, a middle-aged woman. At the time when most countries in the world have been occupied with the coronavirus disease 2019 (COVID-19) pandemic and the recent human monkeypox outbreak, these two outbreaks of EVD have the potential to significantly add to the burden on global health. Authorities need to augment their multi-faceted response, including stringent contact tracing and border control, to avoid the catastrophe of the 2014-2016 EVD epidemic.
Collapse
Affiliation(s)
- Ala'a B. Al-Tammemi
- Migration Health Division, International Organization for Migration (IOM), Amman, Jordan
- Applied Science Research Center, Applied Science Private University, Amman, Jordan
| | - Malik Sallam
- Department of Pathology, Microbiology and Forensic Medicine, School of Medicine, The University of Jordan, Amman, Jordan
- Department of Clinical Laboratories and Forensic Medicine, Jordan University Hospital, Amman, Jordan
- Department of Translational Medicine, Faculty of Medicine, Lund University, Malmö, Sweden
| | - Asem Rebhi
- The Knowledge Company for Medical and Laboratory Supplies, Amman, Jordan
| | - Laarni Soliman
- Migration Health Division, International Organization for Migration (IOM), Doha, Qatar
| | - Lina Al Sarayrih
- Faculty of Pharmacy, Cyprus International University, Nicosia, North Cyprus
| | - Zeinab Tarhini
- Laboratory INSERM U1308, CAPTuR, Control of Cell Activation in Tumor Progression and Therapeutic Resistance, Medical School, Limoges Cedex, France
- EpiMaCT - Epidemiology of Chronic Diseases in Tropical Zone, Institute of Epidemiology and Tropical Neurology, OmegaHealth, Limoges, France
| | - Rana Abutaima
- Faculty of Pharmacy, Zarqa Private University, Zarqa, Jordan
| | - Musheer A. Aljaberi
- Faculty of Medicine and Health Sciences, Taiz University, Taiz, Yemen
- Department of Community Health, Faculty of Medicine and Health Sciences, Universiti Putra Malaysia, Serdang, Malaysia
- Faculty of Nursing and Applied Sciences, Lincoln University College, Petaling Jaya, Malaysia
| | - Muna Barakat
- Department of Clinical Pharmacy and Therapeutics, Faculty of Pharmacy, Applied Science Private University, Amman, Jordan
| |
Collapse
|